Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
2.700
-0.030 (-1.10%)
At close: Jun 22, 2026, 4:00 PM EDT
2.741
+0.041 (1.51%)
After-hours: Jun 22, 2026, 7:52 PM EDT
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $1.13 million as of June 22, 2026. Its market cap has decreased by -85.88% in one year.
Market Cap
1.13M
Enterprise Value
707.29K
1-Year Change
-85.88%
Ranking
Category
Stock Price
$2.70
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.54M to $1.13M, a decrease of -99.24%. That is a compound annual growth rate of -60.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 1.13M | -81.16% |
| Dec 31, 2025 | 6.00M | 86.31% |
| Dec 31, 2024 | 3.22M | -92.32% |
| Dec 21, 2023 | 41.98M | -71.93% |
| Dec 30, 2022 | 149.58M | 4.03% |
| Dec 31, 2021 | 143.79M | -3.20% |
| Apr 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 3.31M |
| VivoSim Labs | 3.27M |
| Virax Biolabs Group | 3.25M |
| Calidi Biotherapeutics | 3.11M |
| Oragenics | 2.61M |
| Bone Biologics | 2.46M |
| Biodexa Pharmaceuticals | 2.25M |
| Valion Bio | 1.64M |